Biocept reported $-2768000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US $ 2018M 429M
Becton, Dickinson and BDX:US $ 360M 94M
Biocept BIOC:US $ -2.77M 0.2M
Celldex Therapeutics CLDX:US $ -36M 12.95M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cytori Therapeutics CYTX:US $ -5.28M 1.17M
General Electric GE:US $ -790M 253M
Illumina ILMN:US $ -535M 621M
Quest Diagnostics DGX:US $ 234M 121M
Thermo Fisher Scientific TMO:US $ 1664M 551M